查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1551555

行动心电遥测系统的全球市场

Mobile Cardiac Telemetry Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 378 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球行动心电遥测系统市场预计将达到 16 亿美元

行动心电遥测系统的全球市场预计到 2023 年将达到 9.767 亿美元，预计到 2030 年将达到 16 亿美元，在 2023-2030 年分析期间复合年增长率为 6.9%。心绞痛适应症是本报告分析的细分市场之一，预计复合年增长率为 8.6%，到分析期结束时将达到 5.627 亿美元。在分析期间，冠状动脉疾病适应症细分市场的复合年增长率预计为 6.8%。

美国市场预估价值2.661亿美元，中国预期复合年增长率为11.3%

预计 2023 年美国行动心电遥测系统市场规模将达 2.661 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达3.475亿美元，2023-2030年分析期间复合年增长率为11.3%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.9% 和 6.9%。在欧洲，德国的复合年增长率预计为 4.4%。

全球行动心电遥测系统市场 - 主要趋势与驱动因素总结

什么是移动心电遥测系统？

移动心臟遥测 (MCT) 系统是心臟监测领域的重要进步，可即时连续观察患者的心臟活动。与传统的心电图监测在有限的时间内记录资料并要求患者返回诊所进行资料分析不同，MCT 系统透过行动网路将心电图资料直接传输给医疗保健提供者。这样可以在发生心律不整或其他心臟事件时立即检测和介入。 MCT 系统的一个关键需求是能够提供及时、准确和可操作的资料，特别是对于高风险患者和标准检查室评估可能无法捕获的短暂性心臟病。这项技术对于诊断心房颤动、心室心搏过速和其他心律不整等疾病尤其重要，如果不及时识别和治疗，这些疾病可能会导致严重甚至致命的后果。此外，MCT 系统重量轻、可穿戴且侵入性较小，提高了患者的依从性和舒适度，使患者能够不间断地进行日常活动。

科技如何提高 MCT 系统的有效性？

行动心电遥测系统背后的技术是先进生物感测器、行动连线和云端基础的分析的复杂结合。 MCT 机器通常包括捕捉心臟电活动的电极、将这些资料即时发送到中央监测站的发送器以及分析异常资讯的软体。人工智慧（AI）和机器学习演算法的整合进一步提高了MCT系统的有效性。这些演算法可以快速识别不规则的心率模式，为医疗保健提供者提供早期警报系统。此外，随着时间的推移储存和分析大型资料集的能力可以识别趋势和模式，从而实现更明智的临床决策并改善患者的治疗结果。现代行动网路的资料传输可靠性和低延迟确保即使是最轻微的心臟功能偏差也能被检测到并快速传达给医疗专业人员。

消费行为在 MCT 系统的实施中扮演什么角色？

消费行为和患者参与在行动心电遥测系统的广泛采用中发挥越来越重要的作用。随着患者更主动地了解自己的健康状况，对提供便利、准确且安心的监测解决方案的需求不断增加。 COVID-19 大流行加速了远端医疗和远距医疗保健服务的转变，进一步凸显了 MCT 等技术的重要性。患者现在熟悉可穿戴设备，并期望将即时健康监测作为其整体护理策略的一部分。此外，MCT 系统的易用性和非侵入性吸引了更广泛的人群，包括不喜欢传统监测方法的老年患者。 MCT 系统的吸引力还在于它与智慧型手机和其他个人装置的无缝整合。患者可以轻鬆追踪自己的健康指标并与医疗保健提供者共用资料，从而获得更个人化的护理。

推动MCT市场成长的因素有哪些？

行动心臟遥测市场的成长是由反映医疗保健和技术发展的几个因素所推动的。主要驱动因素之一是全世界心血管疾病的盛行率不断上升，特别是在老化人口中，心律不整和其他心臟疾病的风险更高。此外，与心臟病密切相关的文明病（例如肥胖、糖尿病和高血压）的日益流行，也推动了对 MCT 等连续监测解决方案的需求。行动技术的进步，包括 4G 和 5G 网路的扩展，也透过实现更快、更可靠的资料传输发挥关键作用，这对于 MCT 系统的即时功能至关重要。此外，对预防性医疗保健和早期诊断的日益关注正在推动医疗保健提供者和患者采用 MCT 系统作为心臟护理的标准部分。多个地区的监管支持和有利的报销政策进一步支持市场成长，使 MCT 系统可供更广泛的患者群体使用。最后，随着市场上更复杂和易于使用的设备的开拓，新用户不断涌现，行动心电遥测系统的市场预计将在未来几年扩大。

受访企业范例（共42例）

  • ACS Diagnostics, Inc.
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Biotricity Inc.
  • Boston Scientific Cardiac Diagnostics Inc.
  • Comarch SA
  • GE HealthCare
  • Infinium Medical, Inc.
  • iRhythm Technologies, Inc.
  • LifeSignals, Inc.
  • Medtronic PLC
  • Philips Healthcare USA
  • ScottCare Cardiovascular Solutions
  • Telerhythmics, LLC
  • Zoll Medical Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26697

Global Mobile Cardiac Telemetry Systems Market to Reach US$1.6 Billion by 2030

The global market for Mobile Cardiac Telemetry Systems estimated at US$976.7 Million in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Angina Pectoris Indication, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$562.7 Million by the end of the analysis period. Growth in the Coronary Artery Diseases Indication segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$266.1 Million While China is Forecast to Grow at 11.3% CAGR

The Mobile Cardiac Telemetry Systems market in the U.S. is estimated at US$266.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$347.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Mobile Cardiac Telemetry Systems Market - Key Trends and Drivers Summarized

What Are Mobile Cardiac Telemetry Systems and Why Are They Critical?

Mobile Cardiac Telemetry (MCT) systems represent a significant advancement in cardiac monitoring, providing real-time, continuous observation of a patient's heart activity. Unlike traditional Holter monitors, which record data for a limited period and require the patient to return to the clinic for data analysis, MCT systems transmit ECG data directly to healthcare providers via mobile networks. This allows for immediate detection and intervention in cases of arrhythmias or other cardiac events. The critical need for MCT systems lies in their ability to provide timely, accurate, and actionable data, especially for high-risk patients or those experiencing transient cardiac symptoms that might not be captured during a standard in-office evaluation. This technology is particularly crucial for diagnosing conditions like atrial fibrillation, ventricular tachycardia, and other arrhythmias, which can have serious or fatal outcomes if not promptly identified and treated. Additionally, MCT systems enhance patient compliance and comfort, as they are lightweight, wearable, and minimally invasive, enabling patients to go about their daily activities without interruption.

How Does Technology Elevate The Effectiveness of MCT Systems?

The technology behind Mobile Cardiac Telemetry systems is a sophisticated blend of advanced biosensors, mobile connectivity, and cloud-based analytics. MCT devices typically include electrodes that capture the heart's electrical activity, a transmitter that sends this data in real-time to a central monitoring station, and software that analyzes the information for any abnormalities. The integration of artificial intelligence (AI) and machine learning algorithms has further elevated the effectiveness of MCT systems. These algorithms can quickly identify irregular patterns in heartbeats, providing an early warning system for healthcare providers. Furthermore, the ability to store and analyze large datasets over time allows for better patient outcomes, as trends and patterns can be identified, leading to more informed clinical decisions. The reliability of data transmission and the low latency of modern mobile networks ensure that even the slightest deviation in heart function is detected and communicated to medical professionals promptly.

What Role Does Consumer Behavior Play in The Adoption of MCT Systems?

Consumer behavior and patient engagement are playing increasingly vital roles in the widespread adoption of Mobile Cardiac Telemetry systems. As patients become more informed and proactive about their health, there is a growing demand for monitoring solutions that offer convenience, accuracy, and peace of mind. The shift toward telemedicine and remote healthcare services, accelerated by the COVID-19 pandemic, has further highlighted the importance of technologies like MCT. Patients are now more comfortable with wearable devices and expect real-time health monitoring as part of their overall care strategy. Additionally, the ease of use and non-invasive nature of MCT systems appeal to a broader demographic, including elderly patients who might be averse to traditional monitoring methods. The ability of these systems to integrate seamlessly with smartphones and other personal devices also contributes to their appeal, as patients can easily track their own health metrics and share data with their healthcare providers, leading to more personalized care.

What Factors Are Driving The Growth of The MCT Market?

The growth in the Mobile Cardiac Telemetry market is driven by several factors that reflect the evolving landscape of healthcare and technology. One of the primary drivers is the increasing prevalence of cardiovascular diseases globally, particularly in aging populations where the risk of arrhythmias and other heart conditions is higher. Additionally, the rising incidence of lifestyle-related conditions, such as obesity, diabetes, and hypertension, which are closely linked to heart disease, has amplified the need for continuous monitoring solutions like MCT. Advances in mobile technology, including the expansion of 4G and 5G networks, have also played a crucial role by enabling faster and more reliable data transmission, which is essential for the real-time capabilities of MCT systems. Moreover, the growing focus on preventive healthcare and early diagnosis is pushing both healthcare providers and patients toward adopting MCT systems as a standard part of cardiac care. Regulatory support and favorable reimbursement policies in several regions have further bolstered market growth, making these systems more accessible to a wider patient base. Lastly, the ongoing development of more sophisticated and user-friendly devices continues to attract new users, ensuring that the market for Mobile Cardiac Telemetry systems will expand in the coming years.

Select Competitors (Total 42 Featured) -

  • ACS Diagnostics, Inc.
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Biotricity Inc.
  • Boston Scientific Cardiac Diagnostics Inc.
  • Comarch SA
  • GE HealthCare
  • Infinium Medical, Inc.
  • iRhythm Technologies, Inc.
  • LifeSignals, Inc.
  • Medtronic PLC
  • Philips Healthcare USA
  • ScottCare Cardiovascular Solutions
  • Telerhythmics, LLC
  • Zoll Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Mobile Cardiac Telemetry Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Mobile and Wireless Technologies Propel Growth in Mobile Cardiac Telemetry Systems
    • Rising Incidence of Cardiovascular Diseases Expands Addressable Market Opportunity for MCT
    • Integration of AI and Predictive Analytics Strengthens the Business Case for Real-Time Cardiac Monitoring
    • Increasing Shift Towards Remote Patient Monitoring Drives Adoption of Mobile Cardiac Telemetry
    • Technological Innovations in Wearable Devices Spur Growth in Continuous Heart Monitoring Solutions
    • Growing Awareness of Preventive Healthcare Generates Demand for Early Detection Tools
    • Emerging Markets and Aging Populations Create New Growth Avenues for MCT Systems
    • Challenges in Data Security and Privacy Create Opportunities for Innovation in Secure MCT Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mobile Cardiac Telemetry Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Angina Pectoris by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Angina Pectoris by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Angina Pectoris by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coronary Artery Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coronary Artery Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Coronary Artery Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Atherosclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Atherosclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Atherosclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Heart Failure & Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Heart Failure & Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Heart Failure & Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiac Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Lead-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Lead-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Lead-based Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Patch-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Patch-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Patch-based Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • JAPAN
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • CHINA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • EUROPE
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • FRANCE
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • GERMANY
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • INDIA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • AFRICA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030

IV. COMPETITION